In This Store
Virchow Group, India manufactures APIs, intermediates and Biotech FDFs. Group companies hold cGMP approvals from USFDA, KFDA, EU and CEPs. APIs include Sulfamethoxazole, Sulfanilamide, Sulfasalazine, Sulfadiazine, sulfapyridine, Trimethoprim, Telmisartan, Olmesartan, Ranitidine, Cephalosporins (Oral and Sterile), Sildenafil, Itraconazole, pregabalin, Levetiracetam. Intermediates include 7-AVCA and GCLE.
BIOTECH products include recombinant biosimilars, Blood Products (Albumin, Immunoglobulin), Probiotics, Oncology and cardiovascular products, Wound care products and Hyaluronic based medical devices. Virchow also undertakes contract manufacture of injectables (PFS, BFS, PEN cartridges) and topicals
Year of Establishment: 1982
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: more than 1000
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: